Wednesday, July 31, 2013

From Kirk Jones and colleagues: Data Set for Reporting of Lung Carcinomas

http://dx.doi.org/10.5858/arpa.2012-0511-OA


Data Set for Reporting of Lung Carcinomas: Recommendations From International Collaboration on Cancer Reporting

Kirk D. Jones MD; Andrew Churg MD; Douglas W. Henderson MBBS, FRCPA; David M. Hwang MD, PhD; Jenny Ma Wyatt ,MBBS, FRCPA; Andrew G. Nicholson DM; Alexandra J. Rice MB, BChir, FRCPath; Mary Kay Washington MD, PhD; Kelly J.Butnor MD
From the Department of Pathology, University of California-San Francisco, San Francisco (Dr Jones); the Department of Pathology, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia (Dr Henderson); the Department of Pathology, University Health Network, Toronto, Ontario, Canada (Dr Hwang); PathWest, QEII Medical Centre, Nedlands, Western Australia (Dr Ma Wyatt [currently at SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia]); the Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, and National Heart and Lung Division, Imperial College, London, United Kingdom (Drs Nicholson and Rice); the Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Washington); and the Department of Pathology, The University of Vermont/Fletcher Allen Health Care, Burlington (Dr Butnor).
Context.—The International Collaboration on Cancer Reporting (ICCR) is a quadripartite alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, and the Canadian Partnership Against Cancer. The ICCR was formed with a view to reducing the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish, and maintain standardized cancer-reporting data sets. The resultant standardization of cancer reporting would be expected to benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets.
Objectives.—To develop an evidence-based reporting data set for each cancer site.
Design.—A project to develop data sets for prostate, endometrium, and lung cancers and malignant melanoma was piloted by the quadripartite group.
Results.—A set of required and recommended data elements and appropriate responses for each element were agreed upon for the reporting of lung cancer.
Conclusions.—This review describes the process of development of the lung cancer data set.

No comments:

Post a Comment